Literature DB >> 34905407

Controlling the Burden of COVID-19 by Manipulating Host Metabolism.

Logan Miller1, Engin Berber1, Deepak Sumbria1, Barry T Rouse1.   

Abstract

The coronavirus disease 2019 (COVID-19) pandemic caused by the coronavirus-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to cause global health problems, but its impact would be minimized if the many effective vaccines that have been developed were available and in widespread use by all societies. This ideal situation is not occurring so other means of controlling COVID-19 are needed. In this short review, we make the case that manipulating host metabolic pathways could be a therapeutic approach worth exploring. The rationale for such an approach comes from the fact that viruses cause metabolic changes in cells they infect, effective host defense mechanisms against viruses requires the activity of one or more metabolic pathways, and that hosts with metabolic defects such as diabetes are more susceptible to severe consequences after COVID-19. We describe the types of approaches that could be used to redirect various aspects of host metabolism and the success that some of these maneuvers have had at controlling other virus infections. Manipulating metabolic activities to control the outcome of COVID-19 has to date received minimal attention. Manipulating host metabolism will never replace vaccines to control COVID-19 but could be used as an adjunct therapy to the extent of ongoing infection.

Entities:  

Keywords:  COVID-19; consequence; immunity; long COVID; metabolism; outcome

Mesh:

Year:  2021        PMID: 34905407      PMCID: PMC8863913          DOI: 10.1089/vim.2021.0150

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  131 in total

1.  On the role of retinoic acid in virus induced inflammatory response in cornea.

Authors:  Ujjaldeep Jaggi; Siva Karthik Varanasi; Siddheshvar Bhela; Barry T Rouse
Journal:  Microbes Infect       Date:  2018-05-26       Impact factor: 2.700

2.  The Nucleotide Sensor ZBP1 and Kinase RIPK3 Induce the Enzyme IRG1 to Promote an Antiviral Metabolic State in Neurons.

Authors:  Brian P Daniels; Sigal B Kofman; Julian R Smith; Geoffrey T Norris; Annelise G Snyder; Joseph P Kolb; Xia Gao; Jason W Locasale; Jennifer Martinez; Michael Gale; Yueh-Ming Loo; Andrew Oberst
Journal:  Immunity       Date:  2019-01-08       Impact factor: 31.745

Review 3.  Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.

Authors:  G Verucchi; L Calza; R Manfredi; F Chiodo
Journal:  Infection       Date:  2004-02       Impact factor: 3.553

4.  Diverse functional autoantibodies in patients with COVID-19.

Authors:  Eric Y Wang; Tianyang Mao; Jon Klein; Yile Dai; John D Huck; Jillian R Jaycox; Feimei Liu; Ting Zhou; Benjamin Israelow; Patrick Wong; Andreas Coppi; Carolina Lucas; Julio Silva; Ji Eun Oh; Eric Song; Emily S Perotti; Neil S Zheng; Suzanne Fischer; Melissa Campbell; John B Fournier; Anne L Wyllie; Chantal B F Vogels; Isabel M Ott; Chaney C Kalinich; Mary E Petrone; Anne E Watkins; Charles Dela Cruz; Shelli F Farhadian; Wade L Schulz; Shuangge Ma; Nathan D Grubaugh; Albert I Ko; Akiko Iwasaki; Aaron M Ring
Journal:  Nature       Date:  2021-05-19       Impact factor: 49.962

Review 5.  COVID-19 and Multiorgan Response.

Authors:  Sevim Zaim; Jun Heng Chong; Vissagan Sankaranarayanan; Amer Harky
Journal:  Curr Probl Cardiol       Date:  2020-04-28       Impact factor: 5.200

Review 6.  COVID-19: Disease, or no disease? - that is the question. It's the dose stupid!

Authors:  Sharvan Sehrawat; Barry T Rouse
Journal:  Microbes Infect       Date:  2021-01-12       Impact factor: 2.700

Review 7.  Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19.

Authors:  Toshifumi Matsuyama; Steven K Yoshinaga; Kimitaka Shibue; Tak W Mak
Journal:  Cell Death Differ       Date:  2021-10-18       Impact factor: 15.828

8.  Characterizing long COVID in an international cohort: 7 months of symptoms and their impact.

Authors:  Hannah E Davis; Gina S Assaf; Lisa McCorkell; Hannah Wei; Ryan J Low; Yochai Re'em; Signe Redfield; Jared P Austin; Athena Akrami
Journal:  EClinicalMedicine       Date:  2021-07-15

9.  Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study.

Authors:  Sufei Wang; Pei Ma; Shujing Zhang; Siwei Song; Zhihui Wang; Yanling Ma; Juanjuan Xu; Feng Wu; Limin Duan; Zhengrong Yin; Huilin Luo; Nian Xiong; Man Xu; Tianshu Zeng; Yang Jin
Journal:  Diabetologia       Date:  2020-07-10       Impact factor: 10.122

10.  SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate.

Authors:  David Olagnier; Ensieh Farahani; Jacob Thyrsted; Julia Blay-Cadanet; Angela Herengt; Manja Idorn; Alon Hait; Bruno Hernaez; Alice Knudsen; Marie Beck Iversen; Mirjam Schilling; Sofie E Jørgensen; Michelle Thomsen; Line S Reinert; Michael Lappe; Huy-Dung Hoang; Victoria H Gilchrist; Anne Louise Hansen; Rasmus Ottosen; Camilla G Nielsen; Charlotte Møller; Demi van der Horst; Suraj Peri; Siddharth Balachandran; Jinrong Huang; Martin Jakobsen; Esben B Svenningsen; Thomas B Poulsen; Lydia Bartsch; Anne L Thielke; Yonglun Luo; Tommy Alain; Jan Rehwinkel; Antonio Alcamí; John Hiscott; Trine H Mogensen; Søren R Paludan; Christian K Holm
Journal:  Nat Commun       Date:  2020-10-02       Impact factor: 14.919

View more
  2 in total

Review 1.  Obesity and COVID-19: What are the Consequences?

Authors:  Charlotte Steenblock; Mohamed Hassanein; Emran G Khan; Mohamad Yaman; Margrit Kamel; Mahmoud Barbir; Dietrich E Lorke; Dean Everett; Saqipi Bejtullah; Tobias Lohmann; Uwe Lindner; Ermal Tahirukaj; Feras Jassim Jirjees; Sameh S M Soliman; Friederike Quitter; Stefan R Bornstein
Journal:  Horm Metab Res       Date:  2022-06-20       Impact factor: 2.788

2.  Long-COVID, Metabolic and Endocrine Disease.

Authors:  Stefan R Bornstein; Diana Cozma; Margrit Kamel; Mawieh Hamad; Mohammad G Mohammad; Naveed A Khan; Maha M Saber; Mohammad H Semreen; Charlotte Steenblock
Journal:  Horm Metab Res       Date:  2022-06-20       Impact factor: 2.788

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.